ArticleOncotarget2016

Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma.

Jun Won Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.